IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy
US11028441B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2017 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Jun 9, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns the use of IL-10 as a biological marker for predicting the responsiveness of a house dust mite allergic patient to house dust mite allergen immunotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.